Search
for
Sort by
Research 361–390 of 1000+
- Environmental Air Pollutants Affecting Skin Functions with Systemic Implications
- MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- Alopecia Areata Associated with Dupilumab: National Database Study
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata
- Large-Scale Preparation of Hair Follicle Germs Using a Microfluidic Device
- Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Progress in studies of epidermal stem cells and their application in skin tissue engineering
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Investigation of hub genes and immune infiltration in androgenetic alopecia using bioinformatics analysis
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Immune therapies for alopecia areata: evidence and new perspectives
- Vitiligo—Current Treatment Options and Future Perspectives
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- New Modalities in the Treatment of Refractory Alopecia Areata
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- New and Emerging Therapies for Alopecia Areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial